Track topics on Twitter Track topics that are important to you
STOCKHOLM, Oct. 12, 2017 /PRNewswire/ --InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod will be issued by the United States Patent and Trademark Office (USPTO). The patent provides additional protection for treating chronic active...
Original Article: InDex Pharmaceuticals AB Gets New Patent In The U.S.NEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...